Drug intelligence / Profile preview

antike

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Antike (also referred to as Antike capsule or AC) is a medicinal product that has been studied in combination with radiotherapy for the treatment of nasopharyngeal cancer. In a clinical context, "Antike capsule" was evaluated for its potential to enhance the effects of radiotherapy in patients with nasopharyngeal carcinoma. However, detailed information about its active ingredients, precise mechanism of action, and broader indications is not available from current sources. The drug appears to be used as an adjunct therapy rather than a primary treatment[4].

Brand names: antike
Other names: antike capsuleAC

Beyond the preview

Go deeper on antike.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on antike.

Explore the full profile